Literature DB >> 16707781

Small, nonpeptide p75NTR ligands induce survival signaling and inhibit proNGF-induced death.

Stephen M Massa1, Youmei Xie, Tao Yang, Anthony W Harrington, Mi Lyang Kim, Sung Ok Yoon, Rosemary Kraemer, Laura A Moore, Barbara L Hempstead, Frank M Longo.   

Abstract

Studies showing that neurotrophin binding to p75NTR can promote cell survival in the absence of Trk (tropomyosin-related kinase) receptors, together with recent structural data indicating that NGF may bind to p75NTR in a monovalent manner, raise the possibility that small molecule p75NTR ligands that positively regulate survival might be found. A pharmacophore designed to capture selected structural and physical chemical features of a neurotrophin domain known to interact with p75NTR was applied to in silico screening of small molecule libraries. Small, nonpeptide, monomeric compounds were identified that interact with p75NTR. In cells showing trophic responses to neurotrophins, the compounds promoted survival signaling through p75NTR-dependent mechanisms. In cells susceptible to proneurotrophin-induced death, compounds did not induce apoptosis but inhibited proneurotrophin-mediated death. These studies identify a unique range of p75NTR behaviors that can result from isolated receptor liganding and establish several novel therapeutic leads.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707781      PMCID: PMC6675309          DOI: 10.1523/JNEUROSCI.3547-05.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

1.  Motoneuron programmed cell death in response to proBDNF.

Authors:  Anna R Taylor; David J Gifondorwa; Mac B Robinson; Jane L Strupe; David Prevette; James E Johnson; Barbara Hempstead; Ronald W Oppenheim; Carolanne E Milligan
Journal:  Dev Neurobiol       Date:  2012-05       Impact factor: 3.964

2.  Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesis.

Authors:  Rick B Meeker; Winona Poulton; Gillian Clary; Michael Schriver; Frank M Longo
Journal:  Exp Neurol       Date:  2015-09-28       Impact factor: 5.330

Review 3.  Molecular evolution of the vertebrate mechanosensory cell and ear.

Authors:  Bernd Fritzsch; Kirk W Beisel; Sarah Pauley; Garrett Soukup
Journal:  Int J Dev Biol       Date:  2007       Impact factor: 2.203

4.  NGF and proNGF regulate functionally distinct mRNAs in PC12 cells: an early gene expression profiling.

Authors:  Mara D'Onofrio; Francesca Paoletti; Ivan Arisi; Rossella Brandi; Francesca Malerba; Luisa Fasulo; Antonino Cattaneo
Journal:  PLoS One       Date:  2011-06-03       Impact factor: 3.240

Review 5.  Understanding proneurotrophin actions: Recent advances and challenges.

Authors:  Kenneth K Teng; Sarah Felice; Taeho Kim; Barbara L Hempstead
Journal:  Dev Neurobiol       Date:  2010-04       Impact factor: 3.964

Review 6.  PROneurotrophins and CONSequences.

Authors:  Rui O Costa; Tânia Perestrelo; Ramiro D Almeida
Journal:  Mol Neurobiol       Date:  2017-04-29       Impact factor: 5.590

Review 7.  Neurotrophic factors in neurodegenerative disorders : potential for therapy.

Authors:  Fabio Fumagalli; Raffaella Molteni; Francesca Calabrese; Paola Francesca Maj; Giorgio Racagni; Marco Andrea Riva
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

8.  Acute administration of the small-molecule p75(NTR) ligand does not prevent hippocampal neuron loss or development of spontaneous seizures after pilocarpine-induced status epilepticus.

Authors:  H L Grabenstatter; J Carlsen; Y H Raol; T Yang; D Hund; Y Cruz Del Angel; A M White; M I Gonzalez; F M Longo; S J Russek; A R Brooks-Kayal
Journal:  J Neurosci Res       Date:  2014-05-07       Impact factor: 4.164

9.  The p75 neurotrophin receptor is expressed by adult mouse dentate progenitor cells and regulates neuronal and non-neuronal cell genesis.

Authors:  Ramon O Bernabeu; Frank M Longo
Journal:  BMC Neurosci       Date:  2010-10-20       Impact factor: 3.288

10.  Signaling through Rho GTPase pathway as viable drug target.

Authors:  Qun Lu; Frank M Longo; Huchen Zhou; Stephen M Massa; Yan-Hua Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.